Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Active, Not Recruiting

A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT04965493

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Ironwood Physicians, Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • Scripps Mercy Hospital San Diego, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions
Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • California Research Institute Los Angeles, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Oncology-Hematology Associates of West Broward Coral Springs, Florida, United States
  • New Jersey Center for Cancer Research Brick, New Jersey, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228

NCT05737628

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • ASST Spedali Civili di Brescia Brescia, Italy
  • Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Italy
  • Instituto Europeo di Oncologia Milan, Italy
  • IRCCS Ospedale San Raffaele Milan, Italy
View Trial Details

Related conditions